TY - JOUR
T1 - Agranulocytosis associated with enalapril
AU - Elis, A.
AU - Lishner, M.
AU - Lang, R.
AU - Ravid, M.
PY - 1991
Y1 - 1991
N2 - An 83-year-old patient developed agranulocytosis following six months of enalapril 10 mg/d. The patient also had received verapamil for three years. Upon discontinuation of both drugs the white blood cell count was rapidly restored. Cases of agranulocytosis due to angiotensin-converting enzyme inhibitors, mainly captopril, have been previously described. We could, however, find no single case associated with verapamil. This, and the very long exposure of the patient to verapamil, support the assumption that this life-threatening complication might have been caused by enalapril.
AB - An 83-year-old patient developed agranulocytosis following six months of enalapril 10 mg/d. The patient also had received verapamil for three years. Upon discontinuation of both drugs the white blood cell count was rapidly restored. Cases of agranulocytosis due to angiotensin-converting enzyme inhibitors, mainly captopril, have been previously described. We could, however, find no single case associated with verapamil. This, and the very long exposure of the patient to verapamil, support the assumption that this life-threatening complication might have been caused by enalapril.
UR - http://www.scopus.com/inward/record.url?scp=0025805509&partnerID=8YFLogxK
U2 - 10.1177/106002809102500502
DO - 10.1177/106002809102500502
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0025805509
SN - 1042-9611
VL - 25
SP - 461
EP - 462
JO - DICP, Annals of Pharmacotherapy
JF - DICP, Annals of Pharmacotherapy
IS - 5
ER -